FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients
Episode von Medizin - Open Access LMU - Teil 22/22 von Ludwig-Maximilians-Universität München · 1. Januar 2014
Background: The objective of this prospectively randomized phase II trial (Trial registration: EUCTR2004-004007-37-DE) was to compare the clinical response of primary breast cancer patients to neoadjuvant therapy with letrozole alone (LET) or letrozole and zoledronic acid (LET + ZOL). Methods: Patients were randomly assigned to receive either LET 2.5 mg/day (n = 79) or the combination of LET 2.5 mg/day and a total of seven infusions of ZOL 4 mg every 4 weeks (n = 89) for 6 months. Primary endpoint was clinical response rate as assessed by mammogram readings. The study was terminated prematurely due to insufficient recruitment. We report here on an exploratory analysis of this data. Results: Central assessment of tumor sizes during the treatment period was available for 131 patients (66 LET, 65 LET + ZOL). Clinical responses (complete or partial) were seen in 54.5% (95% CI: 41.8-66.9) of the patients in the LET arm and 69.2% (95% CI: 56.6-80.1) of those in the LET + ZOL arm (P = 0.106). A multivariate model showed an OR of 1.72 (95% CI: 0.83-3.59) for the experimental arm. Conclusion: No increase in the clinical response rate was observed with the addition of ZOL to a neoadjuvant treatment regimen with LET. However a trend towards a better reponse in the LET + ZOL arm could be observed. This trend is consistent with previous studies that have investigated the addition of ZOL to chemotherapy, and it may support the evidence for a direct antitumor action of zoledronic acid.
Weitere Episoden von „Medizin - Open Access LMU - Teil 22/22“
- A cross-sectional analysis of the effects of residential greenness on blood pressure in 10-year old children: results from the GINIplus and LISAplus studies 1. Januar 2014
- A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant 1. Januar 2014
- A randomised multicentre trial of acupuncture in patients with seasonal allergic rhinitis - trial intervention including physician and treatment characteristics 1. Januar 2014
- Association between anemia and falls in community-dwelling older people: cross-sectional results from the KORA-Age study 1. Januar 2014
- Biological health or lived health: which predicts self-reported general health better? 1. Januar 2014
- Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer 1. Januar 2014
- Comparative cost-effectiveness analyses of cardiovascular magnetic resonance and coronary angiography combined with fractional flow reserve for the diagnosis of coronary artery disease 1. Januar 2014
- Comprehensive analysis of beta-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/beta-catenin signaling 1. Januar 2014
- Contribution of socioeconomic status, stature and birth weight to obesity in Sub-Saharan Africa: cross-sectional data from primary school-age children in Cameroon 1. Januar 2014
- Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study 1. Januar 2014
- Evidence-based decision-making in infectious diseases epidemiology, prevention and control: matching research questions to study designs and quality appraisal tools 1. Januar 2014
- Evidence for significant influence of host immunity on changes in differential blood count during malaria 1. Januar 2014
- Experience of gratitude, awe and beauty in life among patients with multiple sclerosis and psychiatric disorders 1. Januar 2014
- Exploring patterns of accelerometry-assessed physical activity in elderly people 1. Januar 2014
- A comprehensive analysis of Helicobacter pylori plasticity zones reveals that they are integrating conjugative elements with intermediate integration specificity 1. Januar 2014
Alle Episoden von Medizin - Open Access LMU - Teil 22/22 · Mehr Bildung-Podcasts